A project to reorganize businesses acquired through the establishment of new companies or M&A into reporting segments based on the similarity and relatedness of their customers, rather than on the units in which they were acquired, and to share sales structures and management resources. Centered on antibody-related businesses, the aim is to accelerate and improve the efficiency of business operations and research and development.